TGFB1 and neoplasm: The repopulation of the tumor mass after genotoxic therapies is then promoted by the activation of signaling pathways associated with self-renewal and survival-related pathways, typical of CSCs (Notch, Wnt/β-catenin, Hedgehog, TGFβ, PI3K/Akt) [15,41,42,43].